• Actionable intelligence for health sector leaders and advocates.

    Powered by policy analysis, political insight, data and technology.

    broken image
  • Infectious Disease

    Another human case of bird flu is leading researchers to question how we can best understand the virus and better prepare for the possibility of a further outbreak. Read more here.

  • About Us

    Health Policy iQ helps leaders advance solutions to the most pressing health challenges of our time. We partner with stakeholders across the healthcare spectrum from pharmaceutical companies to healthcare providers, specializing in policy research and analysis, strategy and project management.

     

    With a presence in Washington, DC and Munich, Germany, we excel in supporting both U.S. and EU clients with domestic and transatlantic interests.

  • broken image

    Natascha Cumberlidge, Managing Director

    Natascha has more than a decade of healthcare experience in the government, industry and nonprofit sectors - becoming a Senior Legislative Aid for nine-term U.S. Congressman John Tierney, a Vice President in the healthcare practice of the government and public affairs firm Venn Strategies, and a Director at the health policy nonprofit Continuum Health Group. In the public sector, she developed and analyzed legislation related to the Affordable Care Act, Medicare and Medicaid, and drug pricing. She has supported clients on issues including drug pricing and approval, hospital payment policies and critical medicines / medical counter measures, and has led multi-stakeholder coalitions on public health issues like diabetes. Her clients have ranged from pharmaceutical companies and hospital systems to nonprofits and foundations, and her engagement with the U.S. government has spanned Congress, the National Institutes for Health, the Food and Drug Administration and the Biomedical Advanced Research and Development Authority. A bilingual native of Germany who went on to live in the U.S. and Canada, received her Bachelors and Masters degrees in the U.S. and UK, and became a U.S. citizen during her time working on Capitol Hill - Natascha now splits her time between Washington, DC and Munich, Germany, offering multinational clients her perspective in U.S. and European contexts.

  • What we do

    Three practice areas work together to help clients identify priorities - and align their internal and external stakeholders and resources.

    broken image

    Research and Analysis

    In-depth, accessible and audience-specific analysis of policy and regulatory frameworks, medical science, industry dynamics, and public health objectives and outcomes.

    broken image

    Stakeholder Engagement

    Targeted and effective engagement with both public and private sector stakeholders - through direct facilitation and coalition building.

    broken image

    Strategy and Project Management

    Translating health sector insights into timely decision making, clear agendas, and efficient management of people, processes, and data.

  • broken image

    Representative Work

     

    Helping one of the largest philanthropies in the U.S. lay out an agenda for strengthening the U.S. Food and Drug Administration. The work included balancing the FDA's longstanding reliance on rigorous scientific studies and clinical trials with a more recent push to incorporate real world evidence such as patient health records when evaluating drug safety and efficacy. With decades of FDA regulatory process now representing the global gold standard, the FDA's pathway on this issue stands to broadly impact drug development and approval not only in the U.S., but also in the EU and globally.

     

     

     

  • How can we help you?

    Contact us to explore customized support.